Editorial: Autophagy in diseases-From basic to clinic
- PMID: 36685179
- PMCID: PMC9856833
- DOI: 10.3389/fphys.2022.1115511
Editorial: Autophagy in diseases-From basic to clinic
Keywords: autophagy; autophagy regulation; autophagy-related clinical practice; autophagy-related diseases; cardiovascular diseases; diabetes; protozoa.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Comment on
- Editorial on the Research Topic Autophagy in diseases-from basic to clinic
References
-
- Korbut A. I., Taskaeva I. S., Bgatova N. P., Muraleva N. A., Orlov N. B., Dashkin M. V., et al. (2020). SGLT2 inhibitor empagliflozin and DPP4 inhibitor linagliptin reactivate glomerular autophagy in db/db mice, a model of type 2 diabetes. Int. J. Mol. Sci. 21, 2987. 10.3390/ijms21082987 - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources